NRTX-1001

BIOLOGICAL2 trials

Sponsors

Neurona Therapeutics

Conditions

Epilepsy, Temporal LobeMesial Temporal Lobe Epilepsy

Phase 1

A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)

RecruitingNCT06422923

Neurona TherapeuticsEpilepsy, Temporal Lobe

Start: 2024-11-14End: 2042-06-15Target: 10Updated: 2026-01-07

Phase 3

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

RecruitingNCT05135091

Neurona TherapeuticsMesial Temporal Lobe Epilepsy

Start: 2022-06-16End: 2043-09-01Target: 88Updated: 2026-06-09

Related Papers

First-in-Human Trial of NRTX-1001 GABAergic Interneuron Cell Therapy for Treatment of Focal Epilepsy - Emerging Clinical Trial Results (S19.002)

Neurology2024-04-095 citations

EXTH-29. INTERNEURONS THAT BITE, A CELLULAR THERAPY FOR HIGH GRADE GLIOMA

Neuro-Oncology2023-11-01

Human pallial MGE-type GABAergic interneuron cell therapy for chronic focal epilepsy.

2023-10-0146 citations